pRb is dephosphorylated at mitotic exit by the type 1 serine/threonine protein phosphatases (PP1). Here we demonstrate for the ®rst time that mitotic pRb dephosphorylation is a sequential, temporally-regulated event.
Introduction
The identi®cation of the role that the product of the retinoblastoma susceptibility gene, pRb, plays in cell cycle control has been crucial to understanding the cellular response to both growth-promoting and growth-inhibitory signals. One current model states that the restriction point, a time during which a cell commits to the division pathway (Pardee, 1974) , is controlled by cell cycle-dependent pRb phosphorylation (reviewed in Bartek et al., 1996; Herwig and Strauss, 1997) . pRb phosphorylation peaks at S phase and diminishes at exit from mitosis (Buchkovich et al., 1989; Chen et al., 1989; DeCaprio et al., 1989; Mihara et al., 1989; Ludlow et al., 1990) . pRb is thus a substrate for both kinases and serine/threonine protein phosphatases.
As pRb contains 16 dierent consensus cdk sites (Kitagawa et al., 1996) , phosphorylation of pRb can be a complex matter. Phosphorylation of pRb is thought to be carried out by the sequential activation of Cyclin D/cdk4 in mid-G 1 which precedes Cyclin E/cdk2 at the G 1 /S boundary, and Cyclin A/cdk2 in S phase (Lundberg and Weinberg, 1998) . Two-dimensional phosphopeptide mapping has shown that dierent cdks dierentially target phosphorylation sites on pRb (Zarkowska and Mittnacht, 1997) , and that phosphorylation at dierent sites interferes with distinct proteinbinding functions of pRb (Knudsen and Wang, 1996; Zarkowska and Mittnacht, 1997) .
The enzyme that dephosphorylates pRb at mitotic exit is a holoenzyme complex of serine/threonine protein phosphatase type 1 (PP1) (Alberts et al., 1993; Ludlow et al., 1993; Yan and Mumby, 1999) plus interacting subunits that are thought to regulate its activity . PP1 itself is subject to regulation by phosphorylation which appears to temporally control its activity towards pRb, preventing its premature activation so that coordinated cell cycle progression occurs (Dohadwala et al., 1994; Kwon et al., 1997; Liu et al., 1999; Puntoni and Villa-Moruzzi, 1997) . We have previously shown that of the three widespread mammalian isoforms of PP1, the delta isoform has the greatest pRb-directed phosphatase activity .
In continuing our study into the regulation of pRb dephosphorylation, and in light of accumulating evidence for both speci®city of cdks for subsets of pRb phosphorylation sites and sequential pRb phosphorylation, we sought to determine whether the activation of pRb following mitotic exit would also proceed sequentially. The purpose here is to help clarify the functional signi®cance of individual phosphorylation sites. Towards this goal, we made use of a panel of phosphorylation site-speci®c antibodies which allowed for tracking levels of phosphorylation at speci®c ser/thr sites on pRb as cells were released from mitotic block. Use of phosphorylation site-speci®c antibodies to aid in creating protein functionality pro®les is becoming increasingly popular, as evidenced by their use in studying p53 (Nakaya et al., 2000) . Our results support the notion that pRb is indeed dephosphorylated sequentially, in a temporal manner, and that Cyclin D/cdk4 sites are those initially dephosphorylated. Our results also indicate that isoforms of PP1, much like the dierent ckds, have preferences for targeting a subset of pRb phosphorylation sites, and that mitotic-and G 1 phase PP1 isoforms exhibit dierent activities towards each site on pRb. We also address the possible physiological signi®cance of the striking contrast between the pattern of dephosphorylation of Thr821 and Thr826, sites known to be important for disrupting binding of LXCXE-containing proteins to pRb (Knudsen and Wang, 1996; Zarkowska and Mittnacht, 1997) .
Results

pRb is sequentially dephosphorylated at mitotic exit
To determine whether pRb dephosphorylation at mitotic exit proceeded in a sequential, temporal manner, whole-cell lysates were prepared from CV1-P monkey kidney cells following a time course of release from a G 2 /M block. As shown in Table 1 , at least 95% of the starting cells were at the G 2 /M phase following mitotic shake-o. Flow cytometric analysis at the indicated time points of release revealed an increasing population of G 1 cells after 50 min, indicative of mitotic completion. Western blot analyses using pRb phosphorylation site-speci®c antibodies (Tamrakar et al., 1999) revealed that sequential, temporal dephosphorylation of individual cdk sites on pRb occurs during mitotic progression. Figure 1A illustrates this point. As shown, Western blot analyses from the same aliquot of whole-cell lysate reveals a decrease in phospho-Ser807 abundance after 30 min of mitotic release, coincident with an increase in abundance of the faster migrating, hypophosphorylated form of pRb. In contrast, abundance of phospho-Thr356 decreases after 60 min of mitotic release, and that of phospho-Ser608 persists until much later during the time course; 4 h, when a greater population of the cells are in G 1 .
These data also reveal that the sites previously mapped as substrates for Cyclin D/cdk4 and those mapped to Cyclin E/cdk2 (Zarkowska and Mittnacht, 1997) appear to have dierent patterns for dephosphorylation at mitotic exit. As shown in Figure 1B , phosphorylation at the Cyclin D/cdk4 sites proceeds readily in one of two patterns. Ser249, Thr252, Thr356, Ser788 and Ser807 are dephosphorylated at a rapid rate, completed by 50 ± 60 min post mitotic block, when the ®rst signi®cant portion of cells has entered G 1 . Dephosphorylation of Ser780 and Ser608, although proceeding at a slower rate, shows the same general pattern, but disappear much later; at 6 h following release from mitotic arrest (not represented on Figure  1B ). The Cyclin E/cdk2 sites, Thr373 (which may also be targeted by Cyclin D/cdk4) and Ser795 show a markedly dierent course of progression ( Figure 1C) . Initial, rapid dephosphorylation by 40 min is followed by a rapid recovery of phosphorylated band intensity, eventually leveling o as the majority of the cells enter G 1 . These data are in agreement with others who have shown that Ser795 is among the ®rst sites phosphorylated in G 1 (Boylan et al., 1999) .
We also observed a marked dierence in the dephosphorylation rates and levels of two clustered phosphorylation sites. Thr821, a Cyclin E/cdk2 site, and Thr826, a Cyclin D/cdk4-speci®c site, are separated by 4 amino acids in the primary sequence of pRb, and both are part of the C-region of the large pocket domain of pRb. At release from mitotic block, Thr826 dephosphorylation is complete at 40 min, while Thr821 phosphorylation levels remain high, even as cells have entered G 1 after 60 min ( Figure 1D ).
Phosphorylation at Thr821 does not inhibit LXCXE protein binding
Since Thr821 and Thr826 phosphorylation has been shown in a number of dierent studies to be inhibitory to the interaction of GST-pRb with LXCXE-containing proteins such as SV40 T-antigen, Elf-1 and human papillomavirus E7 (Knudsen and Wang, 1996; Zarkowska and Mittnacht, 1997) , we decided to address whether pRb phosphorylation at Thr821 would indeed inhibit LXCXE protein binding. Our approach was to perform coimmunoprecipitation studies using T-antigen expressing cells during a time course of release from a G 2 /M block. This would allow us to obtain populations of cells with pRb dierentially phosphorylated on Thr821 and Thr826. We reasoned that complex formation with T-antigen as a function of dierential pRb phosphorylation would permit an assessment of the relative importance of these phosphorylated sites in T-antigen binding.
Towards this end,¯ow cytometric analysis of Tantigen expressing SV80 cells demonstrated that 50 min following the release from mitotic arrest, only 3% of the cells had reached the ensuing G 1 phase. However, 2 h after release from mitotic block, 51% of cells had entered G 1 , much like CV1-P cells (Table 1) . To compare the phosphorylation status of Thr821 and Thr826 between the SV80 and CV-1P cells, we chose to normalize to G 1 cell content. As such, SV80 cells released from mitotic block for 50 min or 2 h were subjected to separate immunoprecipitations with either antibody to pRb or T-antigen. When both Thr821 and Thr826 were phosphorylated (t=50 min, 82% of cells in G 2 /M), anti-T immunoprecipitates contained little, if (Figure 2 , lane 3, anti-pRb blot). As expected, the reciprocal pRb immunoprecipitation contained a reduced amount of SV40 T-antigen (lane 5, anti-Tantigen blot). In contrast, 2 h post mitotic arrest, when 51% of cells have progressed into the ensuing G 1 phase, and Thr821 alone remains highly phosphorylated, abundant levels of pRb co-immunoprecipitate with T-antigen (Figure 2 , lane 4, anti-pRb blot). The reciprocal immunoprecipitation also demonstrates Tantigen readily co-immunoprecipitating with pRb when Thr821 is phosphorylated (Figure 2 , lane 6, anti-Tantigen blot). Taken together, it appears that little pRb-T-antigen complex exists in mitotic cells when Thr821 and Thr826 are both phosphorylated. However, when cells enter G 1 phase, Thr826 is dephosphorylated, while Thr821 is not. Nevertheless, pRb is capable of binding to this LXCXE-containing protein, suggesting that Thr821 phosphorylation does not interfere with LXCXE binding in vivo.
Thr821 is not targeted by PP1 isoforms in vitro
We were intrigued by the above observation that Thr821 does not exhibit dephosphorylation during our in vivo timecourse, and speculated that perhaps this phospho-residue is not a substrate for PP1. To determine whether Thr821 on pRb can indeed serve as a substrate for PP1, the three widely distributed PP1 isoforms, a, g-1, and d, were immunoprecipitated from mitotic CV1-P cells for use in an in vitro dephosphorylation assay . Mitotic CV1-P extracts were incubated with mitotic PP1 isoform immune complexes for 60 min at 308C, prior to preparation for gel electrophoresis. Western blots were probed with phospho-Thr821 or -Thr826 speci®c antibodies, or anti-pRb for total pRb content, then quantitated by densitometry. Densitometric analysis of these blots revealed that, unlike Thr826 ( Figure 3A bars 4 ± 6), Thr821 was not eciently dephosphorylated by any mitotic PP1 isoform ( Figure 3A bars 1 ± 3), as band intensities did not diminish signi®cantly compared to untreated controls. When PP1 isoforms from G 1 -phase cells were tested for activity at these pRb sites, similar results were obtained ( Figure 3B ). These results are consistent with our ®ndings that Thr821 phosphorylation levels are high following mitotic exit and during other phases of the cell cycle, and may suggest that failure of this site to be dephosphorylated by PP1 is at least partly responsible for this observation. To summarize these data, it appears that pRb phosphorylation at Thr821 does not disappear at mitotic exit ( Figure 1D ), is not targeted eciently by the various PP1 isoforms ( Figure 3A ,B), and does not interfere with the LXCXE protein binding function of pRb (Figure 2 ).
We did observe some dierences in activities of the PP1 isoforms at these phosphorylation sites on pRb ( Figure 3B compare lane 4 to lanes 5 and 6). This intrigued us in light of our earlier data showing that the mitotic d isoform of PP1 was more ecient overall at dephosphorylating pRb in vitro than were the other isoforms . Also, it had recently been reported that dierent cdks phosphorylated only subsets of sites on pRb (Connell-Crowley et al., 1997; Knudsen and Wang, 1996; Zarkowska and Mittnacht, 1997) . We speculated that perhaps the dierent PP1 isoforms could dephosphorylate subsets of the pRb phosphorylation sites.
The greater pRb-directed phosphatase activity of PP1d persists only until G 1 phase
To address whether the dierent PP1 isoforms demonstrated a preference for one or more subsets of pRb phosphorylation sites, we ®rst measured overall pRb-directed phosphatase activity in extracts of cells released from mitotic exit. Consistent with our results shown in Table 1 , release from mitotic block occurred by 60 min after replating nocodazole-treated cells in warm, serum-containing medium (Table 2 ). Figure 4A shows that 50 mg of extracts prepared from these same cells released from mitotic arrest for 30 min (lane 1), 60 min (lane 2) or 2 h (lane 3) eciently dephosphorylated radiolabeled pRb in vitro.
We had earlier shown that the d isoform of mitotic PP1 dephosphorylated pRb in vitro more eciently than did the other isoforms . In experiments presented here, cells were released into the ensuing G 1 phase in order to track the activation of pRb at mitotic exit. Therefore, to measure whether the d isoform had greater pRb-directed phosphatase activity even upon release from mitotic arrest, PP1 was immunoprecipitated using antibodies previously shown to be isoform-speci®c (Tognarini and VillaMoruzzi, 1998 ) from CV1-P cells released from mitotic block as represented in Table 2 . Our results indicate that the d isoform consistently dephosphorylated pRb more eciently until the G 1 fraction of cells increased Figure 3 Thr821 is not dephosphorylated by PP1 isoforms in vitro. Mitotic cell extracts were mixed with immunoprecipitated PP1 isoforms from mitotic (A) or G 1 (B) cells followed by resolution by gel electrophoresis. Western blots were ®rst probed with either phospho-Thr821 (lanes 1 ± 3, white bars), or phosphoThr826 (lanes 4 ± 6, black bars) and then reprobed with anti-pRb. Band intensities were quantitated by densitometry and normalized for total pRb content. Per cent dephosphorylation was calculated by subtracting band intensities from values of untreated controls, dividing by the untreated control band intensity and then multiplying by 100. Results are representative of two dierent experiments A timecourse of CV1-P cell release CV1-P from G 2 /M was as described in Materials and methods. 0.5610 6 cells were removed at the indicated times following release and cell cycle stage determined by¯ow cytometry and DNA histogram analysis. Extracts from cells at the indicated stages of the cycle were used in all subsequent pRbdirected phosphatase assays Oncogene Regulated pRb dephosphorylation by PP1 E Rubin et al to 66% after 2 h ( Figure 4B ). At this point, the activity of all three isoforms was approximately equal ( Figure  4B , bars 10 ± 12). Enzymatic activity of the PP1 isoforms in this fraction of cells were all high, particularly for the a and g-1 isoforms (compare bars 1 and 2, 4 and 5, 7 and 8, with bars 10 and 11), P-labeled immunocomplexed pRb substrate as described in Materials and methods. Proteins were resolved on 6% SDS polyacrylamide gels, dried, and radiolabeled bands were quantitated by phosphorimager analysis. (B) PP1 isoforms were immunoprecipitated from CV1-P cells released from mitotic arrest as per Table 2 . Immune complexes were mixed with radiolabeled pRb and phosphatase activity measurements made as described in Materials and methods. Normal rabbit serum (NRS) immunoprecipitation served as a negative control. Per cent activity was calculated by subtracting the experimental 32 P-labeled pRb band intensity from untreated control intensity, then dividing by the untreated control intensity and multiplying by 100. Results are the average of three trials. Error bars represent the range of values for the three trials Regulated pRb dephosphorylation by PP1 E Rubin et al consistent with the overall greater pRb-directed activity in extracts of these cells ( Figure 4A , bar 3). We therefore conclude that PP1 d has greater pRb-directed enzymatic activity throughout mitosis ( Figure 4B , bars 3, 6, and 9), but this preferential activity does not persist in G 1 .
Mitotic and G 1 PP1 isoforms exhibit different preferences for subsets of pRb phosphorylation sites
Since dierent cdks have speci®city at dierent subsets of phosphorylation sites on pRb (Connell-Crowley et al., 1997; Knudsen and Wang, 1996; Zarkowska and Mittnacht, 1997) , we questioned whether the same would be true of the PP1 isoforms which dephosphorylate pRb. To address this, dephosphorylation assays were carried out using immunocomplexed PP1 isoforms from mitotic cells mixed with extracts from mitotic CV1-P cells. Proteins were resolved by gel electrophoresis and transferred to nitrocellulose for Western blotting with phosphorylation site-speci®c antibodies. Band intensities were quantitated by densitometry, normalized for total pRb content, and converted to per cent dephosphorylation compared to untreated controls. Figure 5A shows how mitotic PP1 isoforms dier in their preferences for one phosphorylation site on pRb. Ser608 is dephosphorylated to an equivalent degree by all mitotic PP1 isoforms compared to an untreated control ( Figure 5A , top blot, compare lanes 2 ± 4 with lane 1). In contrast, Ser249 appears to be dephosphorylated preferentially by the g-1 isoform of mitotic PP1 ( Figure 5A , third blot from the top, compare lane 3 with lanes 2 and 4), despite equivalent levels of total pRb ( Figure 5A , a-pRb blots).
To determine per cent dephosphorylation, band intensities were quantitated by densitometry, normalized for total pRb content, and subtracted from those of untreated controls. Figure 5B shows that mitotic PP1 isoforms dier in their preferences at a subset of sites on pRb. While some phosphorylation sites, such as Ser608 and Ser807 are dephosphorylated to a relatively equivalent degree by all mitotic PP1 isoforms, this is not the case at a number of other phosphorylation sites on pRb. Most notably, Ser249 is targeted for dephosphorylation most eciently by the g-1 isoform of mitotic PP1 (as in Figure 5A ) while Ser788 is dephosphorylated least eciently by the a isoform. We had previously reported on the dierential activity of the mitotic PP1 isoforms toward pRB in vitro . In this earlier study, we were assaying for the overall PP1 activity towards pRb phosphorylated en toto; we were not able at that time to assay for PP1 activity towards individual phosphorylated residues on pRb. In this present report, we now show that individual PP1 isoforms do indeed dier in their preferences for speci®c phosphorylated residues on pRb.
When mitotic cell extracts were treated with immune complexes of PP1 isoforms from G 1 -phase cells, another observation was made. Some sites, such as Ser807 in Figure 5C were dephosphorylated completely by all PP1 isoforms, both mitotic (lanes 2 ± 4) and G 1 -derived (lanes 5 ± 7). Other sites, such as Thr356, are dephosphorylated to dierent degrees by each PP1 preparation. Comparing lanes 5 ± 7 with lanes 2 ± 4 in Figure 5C , it appears that Thr356 is dephosphorylated with greater eciency by the G 1 -phase enzyme preparations.
Quantitative analysis of these phosphatase reactions revealed that G 1 phase PP1 isoforms also display dierences in dephosphorylation eciencies at a number of sites on pRb, again most notably at Ser249 and Ser788 ( Figure 5D ). In addition, a comparison of isoform-speci®c dephosphorylation in Figure 5B ,D reveals a dierence in the observed patterns. If mitotic and G 1 phase PP1 holoenzymes are identical, the graphs in Figure 5B ,D should be very similar. As can be seen, this is not the case. While Ser249 is dephosphorylated most eciently by mitotic PP1 g-1, the reverse is true of the G 1 phase g-1 isoform. Dierences in mitotic and G 1 phase PP1 isoform activity are also observed at Ser788 where PP1a derived from G 1 but not mitotic cells displays greater phosphatase activity at Ser788 than the other isoforms. Consistent with our results in Figure 4A , where cell extracts containing a greater G 1 population dephosphorylated pRb more eciently, we infer that mitotic and G 1 -phase PP1 isoforms are dierentially regulated in their activities towards pRb, which contributes to the apparent temporal and sequential dephosphorylation of pRb.
Discussion
In this study we have undertaken the most comprehensive analysis of the dephosphorylation pattern of pRb at mitotic exit that we are aware of, by utilizing a panel of pRb phosphorylation site-speci®c antibodies. Use of phosphorylation site-speci®c antibodies to aid in creating protein functionality pro®les is becoming increasingly popular, as evidenced by their use in studying p53 (Nakaya et al., 2000) . To summarize our data, we demonstrate, for the ®rst time, that the dephosphorylation of pRb occurs in a sequential, temporally-regulated manner. Dephosphorylation at the sites on pRb studied does not occur at the same rate, nor to the same extent, up to 4 h following the release from G 2 /M arrest, when the majority of cells have entered G 1 . What is the biological signi®cance of this ®nding? It has been known that phosphorylation at dierent sites aects dierent protein binding functions of pRb (Kitagawa et al., 1996; Knudsen and Wang, 1996; Zarkowska and Mittnacht, 1997) , as well as its nuclear sublocation (Mittnacht et al., 1994) and intermolecular interactions (Harbour et al., 1999) thought to be important for its cell cycle regulatory eects (Chew et al., 1998; Connell-Crowley et al., 1997) . Regulated dephosphorylation of pRb supports the idea that the protein-binding functions of pRb are reactivated at dierent times during the return to G 1 . Our data supports the idea that the Cyclin D/cdk4 sites Oncogene Regulated pRb dephosphorylation by PP1 E Rubin et al are the ®rst to undergo dephosphorylation upon release from mitotic block. Since these are the sites ®rst targeted for phosphorylation upon mitogenic stimulation, the functions that these sites mediate must be crucial to pRb's overall growth inhibitory program. The Cyclin E/cdk2 sites, on the other hand, may maintain high levels of phosphorylation, at least until early G 1 , as this will not hinder maintenance in G 1 until further stimulation. As shown here for these cell lines, this is the case for Thr373, Ser795 and Thr821.
One prominent example of the way in which dephosphorylation at dierent sites may activate dierent protein-binding functions of pRb comes from an examination of Thr821 and Thr826 dephosphorylation patterns. While Thr826, a Cyclin D/cdk4 site, is readily and rapidly dephosphorylated following passage through mitosis, Thr821 is not, nor is it targeted by PP1 isoforms in our in vitro experiments. In fact, Thr821 phosphorylation appears at all phases of the cell cycle. Since these sites had earlier been implicated in LXCXE protein binding (Knudsen and Wang, 1996 ; Zarkowska and Mittnacht, 1997), we could not readily explain how Thr821 could remain phosphorylated following entry into G 1 . One possibility was that phosphorylation at Thr821 did not impair pRb function. We sought to test this with respect to the LXCXE-protein binding function of pRb. We were able to co-immunoprecipitate pRb with SV40 Tantigen from SV80 cells following G 2 /M arrest when Thr821 alone remains highly phosphorylated. The pRb/T-antigen complex was not evident by Western blot when both Thr826 and Thr821 are phosphorylated. However, when Thr826 phosphorylation abates, complex formation can be demonstrated. Therefore, Thr821 dephosphorylation does not appear to be required to reactivate pRb's ability to complex with Band intensities from Western blots probed with phosphorylation site-speci®c antibodies as indicated were quantitated by densitometry and normalized for total pRb content. Per cent dephosphorylation by mitotic PP1 isoforms was calculated by subtracting band intensity of each assay from band intensity of untreated control, then dividing by untreated control intensity and multiplying by 100. (C) Comparison between mitotic and G 1 -phase PP1 isoforms is shown in this panel. PP1 isoforms a (lanes 2 and 5) g-1 (lanes 3 and 6) and d (lanes 4 and 7) were immunoprecipitated from either mitotic (lanes 2 ± 4) or G 1 -phase (lanes 5 ± 7) cells mixed with mitotic cell extracts. Lane 1 is an untreated control. (D) Band intensities from Western blots probed with phosphorylation site-speci®c antibodies as indicated were quantitated by densitometry and normalized for total pRb content. Percent dephosphorylation by G 1 -phase PP1 isoforms was calculated by subtracting band intensity of each assay from band intensity of untreated control, then dividing by untreated control intensity and multiplying by 100
an LXCXE-containing protein. In contrast to these results (Zarkowska and Mittnacht, 1997) , others have observed that phosphorylation of either Thr821 with Cyclin A/cdk2 or Thr826 with Cyclin D/cdk4 inhibited SV40 T-antigen binding to GST-pRb. These experiments, however, were performed using GST pull-down assays in vitro, which may not mirror the results we obtained tracking the reactivation of pRb at mitotic exit in vivo.
We have previously reported that the holoenzyme composition of mitotic PP1 isoforms dier from one another and that this may alter their activity towards a single substrate, pRb. In that study , the d isoform of mitotic PP1 dephosphorylated pRb more eciently in vitro than did PP1a or g-1.
PP1d alone was unique in binding a 111-kD interacting subunit which may be the regulatory subunit called PNUTS (Allen et al., 1998) . Our current data suggests that this preferential activity may extend into the ensuing G 1 phase, at which point, the relative catalytic eciencies of each of these isoforms are equalized. When examining relative activities of each of the isoforms on particular phosphorylation sites on pRb, we observed that each enzyme complex has particular speci®cities at a number of sites. Thus, much like the cdks that phosphorylate pRb in G 1 -through S-phase, the enzyme that dephosphorylates pRb at mitotic exit has certain speci®cities for a subset of sites on pRb. Furthermore, for a given PP1 isoform, preferential dephosphorylation at one site will not necessarily be the same for the mitotic-and G 1 -phase form of the enzyme. Since PP1 exists in multimeric complexes with interacting subunits that are not alike for each isoform, there are at least two possible explanations. Either the holoenzyme composition of PP1 plus interacting subunits is dierent for the G 1 and mitotic forms of these phosphatases, or that these noncatalytic subunits are themselves regulated, modulating their activity towards pRb. Some of the PP1-interacting subunits identi®ed to date have been shown to be regulated by phosphorylation (Umstott-Hall et al., 1999; Wera and Hemmings, 1995) , and this may be the case here as well. Preliminary investigation into the subunit compositions of the G 1 form of PP1 seems to suggest that the overall molecular weight of the holoenzyme, 166 kD, is identical to that of its mitotic counterpart (N Krucher and JW Ludlow, unpublished observations). The 111 kD subunit, however, did not appear to be part of the holoenzyme complex. This subunit may be supplanted by the presence of pRb binding to PP1, which is known to occur upon G 1 entry (Durfee et al., 1993; , to ensure that premature pRb phosphorylation and cell cycle progression does not occur. Further investigations to determine PP1-interacting subunits in G 1 phase and their regulation of enzymatic activity are necessary to distinguish between the two possibilities.
In closing, we would like to suggest that the dierential preferences that each mitotic PP1 isoform exhibits towards subsets of phosphorylation sites on pRb may well play a role in reactivation of the suppressive function of pRb. Understanding this process will lead us towards a more complete knowledge of the steps that go awry during oncogenic transformation.
Materials and methods
Cell culture and synchronization CV1-P cells were synchronized in G 1 -phase by incubation in methionine-free Dulbecco's modi®ed Eagle's medium (DMEM) containing 2% dialyzed calf serum as previously described . All incubations were carried out at 378C in a humidi®ed, 5% CO 2 -containing atmosphere. A time course of release from G 1 was accomplished by replating at a density of 1.5610 6 cells per 100 mm culture dish in 10% newborn bovine serum-containing DMEM (Gibco) and incubating for 3, 6, 9, or 12 h. For G 1 -phase CV1-P lysates used in the phosphatase targeting experiments, cells were arrested by contact inhibition when reaching 100% con¯uence in 100 mm plates. Flow cytometric analysis of contact-inhibited cells con®rmed the arrest in G 1 .
CV1-P cells were synchronized in G 2 /M using a nocodazole block . Cells from the mitotic shake-o were elutriated and mitotic cells were pooled and counted. Mitotic cells were replated at a density of 1.0610 6 cells per 10 ml of warm DMEM containing 10% newborn bovine serum. 1.0610 6 cells were removed every 10 min until 60 min and then every 2 h until 6 h. After each interval, cells were prevented from further cell cycle progression by cooling on ice. 0.5610 6 cells were removed for¯ow cytometry, while the remaining cells were lysed for protein analysis.
SV80 human cells, stably transformed with SV40 large Tantigen (Todaro et al., 1966) , were synchronized and elutriated as described above, and the G 2 /M cells pooled. Mitotic cells were released from G 2 /M arrest by replating at a density of 1.0610 6 cells per 10 ml of warm 10% fetal bovine serum-containing DMEM and incubated for 50 min or 2 h. 0.5610 6 cells were removed for¯ow cytometry, while the remaining cells were lysed for protein analysis.
pRb phospho-specific antibody production Antibody to speci®c phosphorylated residues of pRb were raised against 11-mer peptides coupled to tuberculin puri®ed protein derivative (PPD). Using the amino acid sequence of pRb as a guide, peptides were synthesized such that the speci®c phosphorylated residue was located approximately in the middle of the sequence. These coupled peptides were injected into BCG treated rabbits as described by Lussow et al. (1991) . The resulting serum was tested against the peptide used for immunization in an ELISA assay to ensure speci®city, as well as recombinant GST-pRB protein phosphorylated in a site-speci®c manner by cyclin-dependent kinases (Zarkowska and Mittnacht, 1997) . These antibodies have been successfully used by us in de®ning dierentially phosphorylated forms of pRb complexing with type 1 protein phosphatases (Tamrakar et al., 1999) .
Cell lysis, gel electrophoresis and Western blotting
At the indicated times, 0.5610 6 of the harvested cells were lysed by sonication in EBC (50 mM Tris-HCl, pH 8.0, 120 mM NaCl, 0.5% NP-40) supplemented with 1 mg/ml aprotinin (Sigma) and 1 mg/ml of phenylmethylsulfonyl¯uor-ide (PMSF) (Sigma). Protein assays were performed using the BioRad protein assay system according to the manufacturer's instructions and protein concentrations were determined by the software included in a Biorad Smartspec 3000 Spectrophotometer. One hundred mg of total protein per sample was separated by 6% SDS ± PAGE and transferred to nitrocellulose in buer containing 25 mM Tris-HCl, pH 8.5, 192 mM glycine, 20% v/v methanol and 0.01% SDS (Towbin et al., 1979 ). The imprinted membrane was then blocked for 30 min with TBST (20 mM Tris-HCl, pH 8.0, 120 mM NaCl, 0.01% Tween-20) containing 4% nonfat dry milk. Detection of phosphorylated Ser249, Thr252, Thr356, Thr373, Ser608, Ser780, Ser788, Ser795, Ser807, Thr821 and Thr826 was performed by overnight incubation with phosphorylation sitespeci®c antibodies, described above and in a previous report by us (Tamrakar et al., 1999) , diluted 1 : 2000 in TBST containing 2% nonfat dry milk. Total pRb was detected using monoclonal antibody RB-PMG3-245 (Pharmingen). Blots were developed using either horseradish peroxidaseconjugated goat anti-rabbit IgG secondary antibodies (Southern Biotechnology Associates) and enhanced chemiluminescent detection (Pierce) or alkaline phosphatase-conjugated anti-mouse secondary antibodies (Promega) and NBT-BCIP (Sigma). Detection of SV40 large T-antigen using monoclonal antibody pAB-419 (Harlow et al., 1981) was performed as described previously (Ludlow et al., 1990) .
Cell counting, flow cytometry and DNA histogram analysis
For each cell synchronization condition, harvested cells were counted by Coulter Counter (Model ZM, Coulter Electronics, Inc., Miami, FL, USA). Each count and condition was performed in duplicate. 0.5610 6 cells were removed and ®xed in 70% ethanol and stored at 48C until¯ow cytometric analysis. Fixed cells were then centrifuged, resuspended in 1 ml of phosphate buered saline containing 1 mg/ml RNase A, and incubated at room temperature for 30 min. Propidium iodide was added to a ®nal concentration of 10 mg/ml and ow cytometry was performed on a Pro®le II¯ow cytometer (Coulter Electronics, Inc., Hialeah, FL, USA). DNA histogram analysis was performed using the cytologic DNA analysis program provided by Coulter.
Immunoprecipitation
For phosphatase-targeting experiments, PP1 isoforms were immunoprecipitated using isoform-speci®c antibodies (Tognarini and Villa-Moruzzi, 1998) from either mitotic-or G 1 -phase CV1-P cells synchronized as described above, following lysis in EBC supplemented with 10 mg/ml each of aprotinin and PMSF. Isoform-speci®c PP1-immune complexes demonstrated identical phosphorylase a-directed activity and PP1 catalytic subunit abundance as previously determined Tognarini and VillaMoruzzi, 1998; Tamrakar et al., 1999; Tamrakar and Ludlow, 2000) . Subunit composition of mitotic PP1 isoforms has been demonstrated previously. Preliminary experiments indicated that equivalent amounts of each isoform could be immunoprecipitated from CV1-P cells with 4 ml of isoform speci®c antibody and that each immune complex had identical activity towards phosphorylase a, a standard substrate used for quantitating phosphatase activity.
Cell extracts were precleared by incubation with 75 ml of protein A Sepharose (Sigma) diluted 1 : 1 in NET-N (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% NP-40) containing 4% bovine serum albumin. Rabbit antibody to PP1 a, g-1 or d (4 ml) prepared as described in Tognarini and Villa-Moruzzi (1998) was added to lysates together with 100 ml of a 1 : 1 mixture of protein A-Sepharose : NET-N and rocked overnight. Immunoprecipitates were washed three times with 1 ml NET-N and twice with 1 ml phosphatase buer containing 20 mM imidazole, pH 7.0, and 150 mM NaCl, supplemented with 10 ml/ml aprotinin, 1 mM PMSF and 1 mM MnCl 2 . Immunocomplexed PP1 isoforms were detected by Western blot using anti-PP1 antibody FL-18 (Santa Cruz Biotechnology). Activity of PP1 immunoprecipitates was tested using glycogen phosphorylase a (Sigma) as a substrate, as described previously .
For co-immunoprecipitation of pRb and SV40 T-antigen, monoclonal antibody RB PMG3-245, rabbit anti-mouse IgG (Cappell) and protein A-Sepharose were used to precipitate pRb complexes. Monoclonal antibody pAb-419 (Harlow et al., 1981) and protein A-Sepharose were used to precipitate SV40 T-antigen complexes. Immune complexes were washed three times with 1 ml NET-N prior to boiling in 100 ml of sample buer and separation by 6% SDS ± PAGE.
Measure of total and isoform-specific pRb-directed phosphatase activity Mitotic CV1-P cells were prepared and released from nocodazole-induced arrest as described above for 30, 60 or 120 min. At the indicated times, total pRb-directed phosphatase activity in protein extracts of each fraction of cells was measured by mixing 32 P-labeled immunocomplexed pRb substrate with 50 mg of cell extract for 40 min at 308C as described previously (Ludlow et al., 1993; .
To measure isoform-speci®c pRb-directed phosphatase activity, PP1 isoforms were immunoprecipitated as described above and mixed with 32 P-labeled immunocomplexed pRb for 30 min at 308C with occasional mixing. Reactions were terminated by the addition of 3XSDS ± PAGE sample buer and boiled for 10 min. Labeled proteins were separated by 6% SDS ± PAGE, ®xed, dried, visualized by autoradiography and quantitated by phosphorimager analysis on a Molecular Dynamics Storm 860 phosphorimager. Results are presented as per cent activity by quantitating decrease in pRb band intensity relative to controls.
Phosphatase targeting assays
Mitotic CV1-P cell lysates were mixed with mitotic-or G 1 -phase PP1 isoform immunoprecipitates originating from matched amount of protein extract. Reactions were carried out at 308C for 60 min with occasional mixing. Protein aliquots of each reaction (200 mg) were boiled in 3XSDS ± PAGE sample buer prior to separation on 6% SDS gels and analysed by Western blotting.
Densitometric analysis of Western blots and quantitation
Western blots were scanned on a Biorad GS-700 scanner and band intensities quantitated by Biorad Quantity One software. Band intensities were normalized by correcting for any dierences in total pRb content. Results are presented as per cent dephosphorylation relative to controls. For sequential activation of pRb at mitotic exit, normalized band intensities at homologous time points from two experiments were averaged and moving averages plotted as a function of both time of release and mean G 2 /M content. For PP1 targeting experiments, band intensities from a representative of two experiments were normalized by correcting for dierences in total pRb content, and converted to per cent of untreated control. Per cent dephosphorylation was calculated by subtracting this value from 100%.
